mine went up too
#retatrutide 2026-04-06
- two_ml_two — VendorInvestigate came back 97.4 on one lot and 99 on the next from the same SWB, both fine 18:19
- tenpence — right so people insist on small steps because the side effects arrive faster than on the other two 19:16
- tokyo_taper — ok so anyone stayed at 2 for months rather than climbing 20:40
- tokyo_taper — while im here stepping in 1.7 increments instead of doubling is the only thing i would change if i started again 21:22
reconstituted the 30 vial to 8mg/ml specifically so i could take 1 without measuring crumbs
did anyone come off because of the heart rate
watching my heart rate
is there any long term safety data at all or is it phase 2 and hope
[edited]TRIUMPH is phase 3
right so anyone tracking blood pressure alongside the heart rate
[edited]held mine ages
nobody should read my log as a plan, im recording what i did and thats all it is
GI was about the same as tirzepatide for me, the difference was how fast it arrived, we shall see
does the energy expenditure claim show up as anything you can feel
the glucagon arm is the mechanistic story for extra energy expenditure and its still a story to me
cant feel it honestly
Recon calculator: 2mg in 3ml = 10mg/ml.
research use only
triple agonist meaning GLP-1, GIP and glucagon, have i got that right
right so stopped for 12 months and restarted at half my old dose, the ramp was easier second time
VendorInvestigate came back 97.4 on one lot and 99 on the next from the same SWB, both fine
my resting rate went up 3 bpm in the first month and came back most of the way by month 3
i went up too fast, got a fortnight of nothing but nausea, and dropped back two steps
i was wrong to call the heart rate a non issue last year, enough people logged it that i changed my mind
coming back to this the phase 2 weight result was larger than what the earlier agonists reported, in a smaller shorter trial, take that with a pinch of salt
energy expenditure isnt something i could feel, though my sleep tracker disagreed with me, thats one data point
settled by month three
i was wrong to call the heart rate a non issue last year, enough people logged it that i changed my mind
right so people insist on small steps because the side effects arrive faster than on the other two
baseline 58
wk 2 61
wk 4 64
wk 6 67
wk 8 66
wk 10 65 (held dose from wk 7)phase 2 only
triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history, thats one data point
whats the half life like, is it weekly the same way
no long term data
research use only is on every vial and i treat it as exactly that, nobody here is prescribing
the heart rate thing is real enough that i mention it whenever someone asks about starting
the heart rate thing is real enough that i mention it whenever someone asks about starting
phase 2 was still trending at the end which is why the phase 3 readout matters more than usual
whats a sensible starting point, im seeing everything from 0.5 to 2
anyone reconstituting 15 vials to 4 so the steps come out smaller
phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan
did the phase 2 result actually come in higher than the tirzepatide numbers
baseline 58
wk 2 61
wk 4 64
wk 6 67
wk 8 66
wk 10 65 (held dose from wk 7)ok so anyone stayed at 2 for months rather than climbing
glucagon is the new bit
logging rhr daily
the purity spread across lots worries me more than the molecule does
came off at 3 weeks because my resting rate stayed elevated and i didnt like it
while im here stepping in 1.7 increments instead of doubling is the only thing i would change if i started again
back after 2 months, has anything actually been published since
how long before people saw the first change at 2
phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan
triple agonist yeah
smaller steps here
anyone logging resting heart rate on this